Microlax - instructions for use, dose, side effects, contraindications

Similar drugsTo uncover

Dosage form: & nbspsolution for rectal administration.

Composition:

One ml of the solution contains:

Active substances: sodium citrate - 90 mg, sodium lauryl sulfoacetate 70% - 12.9 mg (corresponding to 9 mg sodium lauryl sulfoacetate), sorbitol solution 70% - 893 mg (corresponding to 625 mg sorbitol);

Excipients: sorbic acid - 1 mg, glycerol-125 mg, water purified to 1 ml.

Description:Colorless, opalescent viscous liquid.

Pharmacotherapeutic group:Laxative

ATX: & nbsp

Lauryl sulfate, including in combination with other drugs

Pharmacodynamics:MICROLAX® is a combined preparation that has a laxative effect. The effect occurs in 5-15 minutes. The composition of the drug includes sodium citrate (a peptizing agent that displaces the bound water contained in feces), sodium lauryl sulfoacetate (dilutes the contents of the intestine), and sorbitol (enhances the laxative effect by stimulating the flow of water into the intestine). Increasing the amount of water due to peptization and liquefaction contributes to the softening of stool and facilitates the emptying of the intestine.

Indications:Constipation, incl. with encopresis, preparation for endoscopic (rectoscopy) and X-ray examination of the gastrointestinal tract.

Contraindications:Increased individual sensitivity to the components of the drug.

Pregnancy and lactation:Adequate and strictly controlled studies involving pregnant women were not conducted. Since this drug is probably absorbed into the systemic bloodstream to an insignificant degree, when applied in accordance with the recommendations during pregnancy or lactation, unwanted effects are not expected for the fetus or infant.

Dosing and Administration:

Adults and children over 3 years old

Enter all the contents of one microclystium rectally, inserting the tip to the full length (the length of the universal tip is 60.6 mm, see Figure 1).

Newborns and children under 3 years old

Enter all the contents of one microclystium rectally, inserting the universal tip by half the length (see the mark on the tip, see Figure 1).

Picture 1:

If the complaint persists for a long time, then you need to see a doctor.

For children under 3 years, it is also possible to use microclysters with a shortened tip (the length of the shortened tip is 47.3 mm - see Figure 2). In this case, it is necessary to enter the entire contents of one microclystium rectally, inserting the tip to its full length.

Figure 2:

Instructions for use:

Break off the seal on the tip of the tube.

Lightly press on the tube so that a drop of the drug smears the tip of the enema - this will facilitate the introduction process.

Squeezing the tube, squeeze out all its contents.

Remove the tip, still gently squeezing the tube.

Side effects:

According to spontaneous reports of undesirable phenomena

Undesirable reactions that occur during the use of the drug, which were detected during the post-marketing period, were classified as follows: very frequent (≥10%), frequent (≥1%, but <10%), not frequent (≥0.1% , <1%), rare (≥0.01%, but <0.1%), very rare (<0.01%) and unwanted reactions with unknown frequency of occurrence (incidence rate can not be estimated on the basis of available data ).

Disorders from the gastrointestinal tract. Very rarely: pain in the abdomen (including abdominal discomfort, pain in the abdomen, as well as in the upper abdomen); discomfort in the anorectal area, loose stools.

Impaired immune system. Very rarely: hypersensitivity reactions (eg, urticaria).

Overdose:Not described.

Interaction:There is a risk of developing necrosis of the large intestine with simultaneousoral / rectal administration of sodium polystyrene sulfonate and sorbitol included in the formulation.

Special instructions:

If symptoms persist, avoid prolonged use and consult a doctor.

If the medicine has become unusable or the expiration date has expired, do not throw it into the waste water and throw it out! Place the drug in a bag and put it in the trash. These measures will help protect the environment!

Effect on the ability to drive transp. cf. and fur:MICROLAX® does not affect the ability to drive vehicles and manage machinery.

Form release / dosage:Solution for rectal administration.

Packaging:

5 ml of solution for rectal administration in microclysters for single use (polyethylene tube with a shortened or universal tip and a breaking seal).

By 4 microclysters with a shortened tip together with instructions for use in a cardboard bundle.

For 4 or 12 microclyster with a universal tip along with instructions for use in a cardboard pack.

Storage conditions:At a temperature not higher than 25 ° C in a place inaccessible to children.

Shelf life:

5 years.Do not use after the expiry date printed on the package.

Note:

The marking of the expiry date on the package (the period from the production date to the date specified in the item "go to") may be less than 5 years for 1 month.

Terms of leave from pharmacies:Without recipe

Registration number:П N011146 / 01

Date of registration:05.05.2010 / 02.04.2015

Expiration Date:Unlimited

The owner of the registration certificate:Johnson & Johnson, LLC Johnson & Johnson, LLC Russia

Manufacturer: & nbsp

FAMAR ORLEANS France

Representation: & nbspJohnson & Johnson LLC Johnson & Johnson LLC Russia

Information update date: & nbsp08.06.2018

Illustrated instructions

Instructions

Microlax® (Microlax®)